MT Newswires9d agoneutral
Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $61 From $63News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.76d agoneutral
Pfizer Stock: Wall Street Sees a Rebound, Here’s Our Price TargetStockStory99d agobullish
BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook